Melanoma with in-frame deletion of MAP2K1: a distinct molecular subtype of cutaneous melanoma mutually exclusive from BRAF, NRAS, and NF1 mutations
Open Access
- 1 December 2020
- journal article
- research article
- Published by Elsevier BV in Laboratory Investigation
- Vol. 33 (12), 2397-2406
- https://doi.org/10.1038/s41379-020-0581-5
Abstract
No abstract availableThis publication has 63 references indexed in Scilit:
- Signatures of mutational processes in human cancerNature, 2013
- A Landscape of Driver Mutations in MelanomaCell, 2012
- Preexisting MEK1 Exon 3 Mutations in V600E/K BRAF Melanomas Do Not Confer Resistance to BRAF InhibitorsCancer Discovery, 2012
- Exome sequencing identifies recurrent somatic MAP2K1 and MAP2K2 mutations in melanomaNature Genetics, 2011
- Dissecting Therapeutic Resistance to RAF Inhibition in Melanoma by Tumor Genomic ProfilingJournal of Clinical Oncology, 2011
- Genetic and morphologic features for melanoma classificationPigment Cell & Melanoma Research, 2010
- MEK1 mutations confer resistance to MEK and B-RAF inhibitionProceedings of the National Academy of Sciences of the United States of America, 2009
- Novel MEK1 Mutation Identified by Mutational Analysis of Epidermal Growth Factor Receptor Signaling Pathway Genes in Lung AdenocarcinomaCancer Research, 2008
- Improving Melanoma Classification by Integrating Genetic and Morphologic FeaturesPLoS Medicine, 2008
- Distinct Sets of Genetic Alterations in MelanomaThe New England Journal of Medicine, 2005